Results 291 to 300 of about 72,745 (313)

Mitral regurgitation at the time of left ventricular assist device implantation: Should it be treated or not? [PDF]

JTCVS Open
Kohno H, Matsumiya G, Saiki Y, Kinugawa K, Ono M.   +4 more
europepmc   +1 more source

Cost-Effectiveness of Left Ventricular Assist Device for Transplant-Ineligible Patients.

JAMA Netw Open
Schaffer EM, Su RGS, Chay J, Finkelstein EA.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

Left ventricular noncompaction cardiomyopathy: cardiac, neuromuscular, and genetic factors

Nature Reviews Cardiology, 2017
Josef Finsterer, Claudia Stöllberger, Jeffrey A Towbin   +2 more
exaly  

Liquid biopsy and minimal residual disease — latest advances and implications for cure

Nature Reviews Clinical Oncology, 2019
Klaus Pantel, Catherine Alix-Panabières
exaly  

A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans

Nature, 2003
Oliver Hobert, Robert J Johnston Jr
exaly  

Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice

Signal Transduction and Targeted Therapy, 2022
exaly  

Left main coronary artery disease: pathophysiology, diagnosis, and treatment

Nature Reviews Cardiology, 2018
Carlos Collet, Davide Capodanno, Adrian Banning   +2 more
exaly  

Determination of left–right patterning of the mouse embryo by artificial nodal flow

Nature, 2002
Shigenori Nonaka, 野中茂紀, Hiroshi Hamada   +1 more
exaly